Nikos Panayotatos

Title: Innovations of Nikos Panayotatos in Gene Expression

Introduction

Nikos Panayotatos is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of gene expression. His innovative work has led to the development of a patent that enhances the expression of cloned genes.

Latest Patents

Nikos Panayotatos holds a patent titled "Vectors for increased expression of cloned genes." This patent describes improved expression vectors designed to amplify the expression of a DNA sequence encoding a desired polypeptide beyond what is typically expected based on the vector copy number. The vector incorporates a DNA sequence within its replicon that encodes RNA I and the primer RNA necessary for initiating DNA replication. Notably, the DNA sequence features an AT to GC mutation at position 3029 in the two strands of pBR322. This mutation, along with a promoter of RNA I or primer RNA and a restriction site for inserting a DNA sequence, significantly increases the vector copy number, thereby enhancing the expression of the desired polypeptide.

Career Highlights

Nikos Panayotatos is currently associated with Biogen N.V., a leading biotechnology company. His role at Biogen allows him to further his research and development efforts in the field of gene therapy and biotechnology. His expertise and innovative mindset have positioned him as a valuable asset in the industry.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Nikos Panayotatos is a prominent inventor whose work in gene expression has the potential to revolutionize biotechnology. His patent on improved expression vectors showcases his innovative approach to amplifying gene expression, contributing to advancements in the field.